{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:39:28Z","timestamp":1792366768080,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":95,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This study was supported by the Medical Science Research Project of Hebei","award":["20200933"],"award-info":[{"award-number":["20200933"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60821-2","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:14:42Z","timestamp":1784236482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integration of molecular docking, molecular dynamics simulations, and free energy calculations identifies a novel flavonoid glycoside as a PCSK9 inhibitor for hypercholesterolemia"],"prefix":"10.1038","volume":"16","author":[{"given":"Yanwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"60821_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12933-024-02281-4","volume":"23","author":"X Zhu","year":"2024","unstructured":"Zhu, X. et al. Changes in the combination of the triglyceride-glucose index and obesity indicators estimate the risk of cardiovascular disease. Cardiovasc. Diabetol. 23, 192. https:\/\/doi.org\/10.1186\/s12933-024-02281-4 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"60821_CR2","doi-asserted-by":"publisher","unstructured":"Global Burden of Cardiovascular Diseases and Risks 202 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990\u20132023. J. Am. Coll. Cardiol. 86, 2167\u20132243. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.015 (2025).","DOI":"10.1016\/j.jacc.2025.08.015"},{"key":"60821_CR3","doi-asserted-by":"publisher","unstructured":"Fr\u0105k, W. et al. Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease. Biomedicines 10. (2022). https:\/\/doi.org\/10.3390\/biomedicines10081938","DOI":"10.3390\/biomedicines10081938"},{"key":"60821_CR4","doi-asserted-by":"publisher","first-page":"1273596","DOI":"10.3389\/fcvm.2023.1273596","volume":"10","author":"L Luo","year":"2023","unstructured":"Luo, L., Fu, C., Bell, C. F., Wang, Y. & Leeper, N. J. Role of vascular smooth muscle cell clonality in atherosclerosis. Front. Cardiovasc. Med. 10, 1273596. https:\/\/doi.org\/10.3389\/fcvm.2023.1273596 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"60821_CR5","doi-asserted-by":"publisher","unstructured":"Martini, S. et al. Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens. Pathogens 12. (2023). https:\/\/doi.org\/10.3390\/pathogens12070925","DOI":"10.3390\/pathogens12070925"},{"key":"60821_CR6","doi-asserted-by":"publisher","first-page":"e2422558","DOI":"10.1001\/jamanetworkopen.2024.22558","volume":"7","author":"L Chen","year":"2024","unstructured":"Chen, L. et al. Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China. JAMA Netw. Open. 7, e2422558. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.22558 (2024).","journal-title":"JAMA Netw. Open."},{"key":"60821_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.56782\/pps.241","volume":"22","author":"P Lis","year":"2024","unstructured":"Lis, P. et al. Inclisiran - a new solution for the prevention and treatment of atherosclerotic cardiovascular disease. Prospects Pharm. Sci. 22, 136\u2013141. https:\/\/doi.org\/10.56782\/pps.241 (2024).","journal-title":"Prospects Pharm. Sci."},{"key":"60821_CR8","doi-asserted-by":"publisher","unstructured":"Zhu, B. et al. Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin\/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation. bioRxiv. (2025). https:\/\/doi.org\/10.1101\/2024.08.26.609742","DOI":"10.1101\/2024.08.26.609742"},{"key":"60821_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.56782\/pps.208","volume":"22","author":"P D\u0105browska","year":"2024","unstructured":"D\u0105browska, P., \u017buber, M. & Dacka, M. Efficacy and safety of bempedoic acid in lipid disorder therapy: a review of clinical trials. Prospects Pharm. Sci. 22, 120\u2013126. https:\/\/doi.org\/10.56782\/pps.208 (2024).","journal-title":"Prospects Pharm. Sci."},{"key":"60821_CR10","first-page":"19","volume":"85","author":"GW Go","year":"2012","unstructured":"Go, G. W. & Mani, A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J. Biol. Med. 85, 19\u201328 (2012).","journal-title":"Yale J. Biol. Med."},{"key":"60821_CR11","doi-asserted-by":"publisher","unstructured":"Ji, E. & Lee, S. Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22115770 (2021).","DOI":"10.3390\/ijms22115770"},{"key":"60821_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.atherosclerosis.2019.09.009","volume":"292","author":"V Valenti","year":"2020","unstructured":"Valenti, V. et al. PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study. Atherosclerosis 292, 209\u2013214. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.09.009 (2020).","journal-title":"Atherosclerosis"},{"key":"60821_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.14336\/ad.2024.0922","volume":"16","author":"Y Zeng","year":"2024","unstructured":"Zeng, Y., Buonfiglio, F., Li, J., Pfeiffer, N. & Gericke, A. Mechanisms Underlying Vascular Inflammaging: Current Insights and Potential Treatment Approaches. Aging Dis. 16, 1889\u20131917. https:\/\/doi.org\/10.14336\/ad.2024.0922 (2024).","journal-title":"Aging Dis."},{"key":"60821_CR14","doi-asserted-by":"publisher","first-page":"1327185","DOI":"10.3389\/fphar.2023.1327185","volume":"14","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. PCSK-9 inhibitors: a new direction for the future treatment of ischemic stroke. Front. Pharmacol. 14, 1327185. https:\/\/doi.org\/10.3389\/fphar.2023.1327185 (2023).","journal-title":"Front. Pharmacol."},{"key":"60821_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fcvm.2018.00199","volume":"5","author":"T Nishikido","year":"2018","unstructured":"Nishikido, T. & Ray, K. K. Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries. Front. Cardiovasc. Med. 5, 199. https:\/\/doi.org\/10.3389\/fcvm.2018.00199 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"60821_CR16","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.drudis.2018.09.002","volume":"23","author":"M Danhof","year":"2018","unstructured":"Danhof, M., Klein, K., Stolk, P., Aitken, M. & Leufkens, H. The future of drug development: the paradigm shift towards systems therapeutics. Drug Discov Today. 23, 1990\u20131995. https:\/\/doi.org\/10.1016\/j.drudis.2018.09.002 (2018).","journal-title":"Drug Discov Today"},{"key":"60821_CR17","doi-asserted-by":"publisher","first-page":"100075","DOI":"10.1016\/j.medidd.2020.100075","volume":"9","author":"FD Makurvet","year":"2021","unstructured":"Makurvet, F. D. Biologics vs. small molecules: Drug costs and patient access. Med. Drug Discovery. 9, 100075. https:\/\/doi.org\/10.1016\/j.medidd.2020.100075 (2021).","journal-title":"Med. Drug Discovery"},{"key":"60821_CR18","doi-asserted-by":"publisher","first-page":"8978","DOI":"10.1021\/acsabm.0c01229","volume":"3","author":"V Harbour","year":"2020","unstructured":"Harbour, V. et al. Regulation of Lipoprotein Homeostasis by Self-Assembling Peptides. ACS Appl. Bio Mater. 3, 8978\u20138988. https:\/\/doi.org\/10.1021\/acsabm.0c01229 (2020).","journal-title":"ACS Appl. Bio Mater."},{"key":"60821_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.56782\/pps.455","volume":"23","author":"A Kumar Patel","year":"2025","unstructured":"Kumar Patel, A., Chandra, P., Sachan, N., Singh, N. & Chatterjee, S. Elucidating the phytochemical profile and therapeutic potentials of Moringa oleifera: an integrative approach. Prospects Pharm. Sci. 23, 115\u2013126. https:\/\/doi.org\/10.56782\/pps.455 (2025).","journal-title":"Prospects Pharm. Sci."},{"key":"60821_CR20","doi-asserted-by":"publisher","first-page":"115791","DOI":"10.1016\/j.ejmech.2023.115791","volume":"260","author":"J Li","year":"2023","unstructured":"Li, J. et al. Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery. Eur. J. Med. Chem. 260, 115791. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115791 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"60821_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.56782\/pps.286","volume":"22","author":"M Yazar","year":"2024","unstructured":"Yazar, M. et al. General properties, biosynthesis, pharmacological properties, biological activities and daily uses of luteolin. Prospects Pharm. Sci. 22, 146\u2013154. https:\/\/doi.org\/10.56782\/pps.286 (2024).","journal-title":"Prospects Pharm. Sci."},{"key":"60821_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s42250-026-01590-3","volume":"9","author":"Z Jebli","year":"2026","unstructured":"Jebli, Z., Horchani, M., Jannet, H. B., Salem, R. B. & Rigane, G. Anti-Inflammatory and Antibacterial Activities with Molecular Docking Studies of Optimized Passion Fruit Extract. Chem. Afr. 9, 86. https:\/\/doi.org\/10.1007\/s42250-026-01590-3 (2026).","journal-title":"Chem. Afr."},{"key":"60821_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12161-026-03015-w","volume":"19","author":"W Sun","year":"2026","unstructured":"Sun, W. et al. LC-QTOF\/MS-Based Non-targeted Metabolomics Combined with Machine Learning Algorithms for Geographical Origin Discrimination of Yongfu Luohan Guo (Siraitia grosvenorii). Food. Anal. Methods. 19, 91. https:\/\/doi.org\/10.1007\/s12161-026-03015-w (2026).","journal-title":"Food. Anal. Methods"},{"key":"60821_CR24","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1007\/s11696-023-02994-y","volume":"77","author":"M Gackowski","year":"2023","unstructured":"Gackowski, M., Madriwala, B. & Koba, M. In silico design, docking simulation, and ANN-QSAR model for predicting the anticoagulant activity of thiourea isosteviol compounds as FXa inhibitors. Chem. Pap. 77, 7027\u20137044. https:\/\/doi.org\/10.1007\/s11696-023-02994-y (2023).","journal-title":"Chem. Pap."},{"key":"60821_CR25","doi-asserted-by":"publisher","unstructured":"Gackowski, M., Madriwala, B., Studzinska, R. & Koba, M. Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation. Molecules 28 https:\/\/doi.org\/10.3390\/molecules28134977 (2023).","DOI":"10.3390\/molecules28134977"},{"key":"60821_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10822-025-00648-7","volume":"39","author":"K M\u0105dra-Gackowska","year":"2025","unstructured":"M\u0105dra-Gackowska, K. et al. Computational QSAR study of novel 2-aminothiazol-4(5H)-one derivatives as 11\u03b2-HSD1 inhibitors. J. Comput. Aided Mol. Des. 39, 67. https:\/\/doi.org\/10.1007\/s10822-025-00648-7 (2025).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"60821_CR27","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 58, 4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104 (2015).","journal-title":"J. Med. Chem."},{"key":"60821_CR28","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1038\/s41467-025-60989-7","volume":"16","author":"J Lu","year":"2025","unstructured":"Lu, J. et al. ToxACoL: an endpoint-aware and task-focused compound representation learning paradigm for acute toxicity assessment. Nat. Commun. 16, 5992. https:\/\/doi.org\/10.1038\/s41467-025-60989-7 (2025).","journal-title":"Nat. Commun."},{"key":"60821_CR29","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"60821_CR30","doi-asserted-by":"publisher","unstructured":"Al Azzam, K. M. SwissADME and pkCSM Webservers Predictors: an integrated Online Platform for Accurate and Comprehensive Predictions for In Silico ADME\/T Properties of Artemisinin and its Derivatives. Kompleksnoe Ispolzovanie Mineralnogo Syra. 14\u201321. https:\/\/doi.org\/10.31643\/2023\/6445.13 (2023).","DOI":"10.31643\/2023\/6445.13"},{"key":"60821_CR31","doi-asserted-by":"publisher","first-page":"107760","DOI":"10.1016\/j.mtcomm.2023.107760","volume":"38","author":"N Innan","year":"2024","unstructured":"Innan, N., Khan, M. A. Z. & Bennai, M. Quantum computing for electronic structure analysis: Ground state energy and molecular properties calculations. Mater. Today Commun. 38, 107760. https:\/\/doi.org\/10.1016\/j.mtcomm.2023.107760 (2024).","journal-title":"Mater. Today Commun."},{"key":"60821_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.saa.2012.11.097","volume":"105","author":"AC Costa Jr","year":"2013","unstructured":"Costa, A. C. Jr. et al. DFT: B3LYP\/6-311G (d, p) vibrational analysis of bis-(diethyldithiocarbamate)zinc(II) and natural bond orbitals. Spectrochim Acta Mol. Biomol. Spectrosc. 105, 251\u2013258. https:\/\/doi.org\/10.1016\/j.saa.2012.11.097 (2013).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"60821_CR33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nsmb.3453","volume":"24","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists. Nat. Struct. Mol. Biol. 24, 848\u2013856. https:\/\/doi.org\/10.1038\/nsmb.3453 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"60821_CR34","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256 (2009).","journal-title":"J. Comput. Chem."},{"key":"60821_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-9752-7_9","volume":"2053","author":"G Bitencourt-Ferreira","year":"2019","unstructured":"Bitencourt-Ferreira, G., Pintro, V. O. & de Azevedo, W. F. Jr. Docking with AutoDock4. Methods Mol. Biol. 2053, 125\u2013148. https:\/\/doi.org\/10.1007\/978-1-4939-9752-7_9 (2019).","journal-title":"Methods Mol. Biol."},{"key":"60821_CR36","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/jcc.21478","volume":"31","author":"J Fuhrmann","year":"2010","unstructured":"Fuhrmann, J., Rurainski, A., Lenhof, H. P. & Neumann, D. A new Lamarckian genetic algorithm for flexible ligand-receptor docking. J. Comput. Chem. 31, 1911\u20131918. https:\/\/doi.org\/10.1002\/jcc.21478 (2010).","journal-title":"J. Comput. Chem."},{"key":"60821_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcc.540020311","volume":"2","author":"PK Weiner","year":"1981","unstructured":"Weiner, P. K. & Kollman, P. A. AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions. J. Comput. Chem. 2, 287 (1981).","journal-title":"J. Comput. Chem."},{"key":"60821_CR38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1021\/acs.jctc.2c00725","volume":"19","author":"HC Tsai","year":"2023","unstructured":"Tsai, H. C. et al. AMBER Free Energy Tools: A New Framework for the Design of Optimized Alchemical Transformation Pathways. J. Chem. Theory Comput. 19, 640 (2023).","journal-title":"J. Chem. Theory Comput."},{"key":"60821_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution. J. Chem. Theory Comput. 16, 528\u2013552. https:\/\/doi.org\/10.1021\/acs.jctc.9b00591 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"60821_CR40","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1021\/acs.jctc.8b01039","volume":"15","author":"D Vassetti","year":"2019","unstructured":"Vassetti, D., Pagliai, M. & Procacci, P. Assessment of GAFF2 and OPLS-AA General Force Fields in Combination with the Water Models TIP3P, SPCE, and OPC3 for the Solvation Free Energy of Druglike Organic Molecules. J. Chem. Theory Comput. 15, 1983\u20131995. https:\/\/doi.org\/10.1021\/acs.jctc.8b01039 (2019).","journal-title":"J. Chem. Theory Comput."},{"key":"60821_CR41","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1021\/j100142a004","volume":"97","author":"CI Bayly","year":"1993","unstructured":"Bayly, C. I., Cieplak, P., Cornell, W. & Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J. Phys. Chem. 97, 10269 (1993).","journal-title":"J. Phys. Chem."},{"key":"60821_CR42","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/08927022.2016.1183000","volume":"42","author":"A Peramo","year":"2016","unstructured":"Peramo, A. Solvated and generalised Born calculations differences using GPU CUDA and multi-CPU simulations of an antifreeze protein with AMBER. Mol. Simul. 42, 1263\u20131273. https:\/\/doi.org\/10.1080\/08927022.2016.1183000 (2016).","journal-title":"Mol. Simul."},{"key":"60821_CR43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jcp.2006.05.032","volume":"220","author":"P Gonnet","year":"2007","unstructured":"Gonnet, P. P-SHAKE:: A quadratically convergent SHAKE in O(n2). J. Comput. Phys. 220, 740\u2013750. https:\/\/doi.org\/10.1016\/j.jcp.2006.05.032 (2007).","journal-title":"J. Comput. Phys."},{"key":"60821_CR44","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R. & Cheatham, T. E. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J. Chem. Theory Comput. 9, 3084\u20133095. https:\/\/doi.org\/10.1021\/ct400341p (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"60821_CR45","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/jcc.25382","volume":"39","author":"DR Roe","year":"2018","unstructured":"Roe, D. R. & Cheatham, T. E. Parallelization of CPPTRAJ Enables Large Scale Analysis of Molecular Dynamics Trajectory Data. J. Comput. Chem. 39, 2110\u20132117. https:\/\/doi.org\/10.1002\/jcc.25382 (2018).","journal-title":"J. Comput. Chem."},{"key":"60821_CR46","doi-asserted-by":"publisher","DOI":"10.1021\/ci300425v","author":"PA Greenidge","year":"2013","unstructured":"Greenidge, P. A., Kramer, C., Mozziconacci, J. C. & Wolf, R. M. Successes, Failures, and Directions for Further Improvement. J. Chem. Inf. Model. 53, 201\u2013209. https:\/\/doi.org\/10.1021\/ci300425v (2013). MM\/GBSA Binding Energy Prediction on the PDBbind Data Set:."},{"key":"60821_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"60821_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1389200222666210705122913","volume":"22","author":"NE Daoud","year":"2021","unstructured":"Daoud, N. E. et al. ADMET Profiling in Drug Discovery and Development: Perspectives of In Silico, In Vitro and Integrated Approaches. Curr. Drug Metab. 22, 503\u2013522. https:\/\/doi.org\/10.2174\/1389200222666210705122913 (2021).","journal-title":"Curr. Drug Metab."},{"key":"60821_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/molecules30142962","volume":"30","author":"XY Wu","year":"2025","unstructured":"Wu, X. Y. et al. Insights into Binding Mechanisms of Potential Inhibitors Targeting PCSK9 Protein via Molecular Dynamics Simulation and Free Energy Calculation. Molecules 30, 20. https:\/\/doi.org\/10.3390\/molecules30142962 (2025).","journal-title":"Molecules"},{"key":"60821_CR50","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/cmdc.202000431","volume":"15","author":"J Sgrignani","year":"2020","unstructured":"Sgrignani, J., Fassi, E. M. A., Lammi, C., Roda, G. & Grazioso, G. Exploring Proprotein Convertase Subtilisin\/Kexin 9 (PCSK9) Autoproteolysis Process by Molecular Simulations: Hints for Drug Design. Chemmedchem 15, 1601\u20131607. https:\/\/doi.org\/10.1002\/cmdc.202000431 (2020).","journal-title":"Chemmedchem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60821-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60821-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60821-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:42:06Z","timestamp":1792363326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60821-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60821-2","relation":{"references":[{"id-type":"doi","id":"10.1021\/ci300425v","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32722"}}